| scholarly article | Q13442814 |
| P50 | author | Nicolas Gervasi | Q56501492 |
| P2093 | author name string | M L Tremblay | |
| C Faure | |||
| M Vigny | |||
| M C Boutterin | |||
| P Mazot | |||
| S Doly | |||
| P2860 | cites work | Identification of ALK as a major familial neuroblastoma predisposition gene | Q24655923 |
| Oncogenic mutations of ALK kinase in neuroblastoma | Q39928776 | ||
| P433 | issue | 6 | |
| P921 | main subject | phosphorylation | Q242736 |
| P1104 | number of pages | 9 | |
| P304 | page(s) | 1505-1513 | |
| P577 | publication date | 2013-03-14 | |
| P1433 | published in | Cellular Signalling | Q1524097 |
| P1476 | title | Control of ALK (wild type and mutated forms) phosphorylation: specific role of the phosphatase PTP1B | |
| P478 | volume | 25 |
| Q27310990 | ALK kinase domain mutations in primary anaplastic large cell lymphoma: consequences on NPM-ALK activity and sensitivity to tyrosine kinase inhibitors |
| Q50026220 | Interrogating Protein Phosphatases with Chemical Activity Probes |
| Q91979927 | Protein tyrosine phosphatase PTPN1 modulates cell growth and associates with poor outcome in human neuroblastoma |
| Q55422121 | The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII. |
| Q41116766 | The use of cellular thermal shift assay (CETSA) to study Crizotinib resistance in ALK-expressing human cancers. |
| Q28546245 | Understanding the Interplay between Expression, Mutation and Activity of ALK Receptor in Rhabdomyosarcoma Cells for Clinical Application of Small-Molecule Inhibitors |
| Q34101007 | Wild-type ALK and activating ALK-R1275Q and ALK-F1174L mutations upregulate Myc and initiate tumor formation in murine neural crest progenitor cells |
Search more.